VOTIS Subdermal Imaging Technologies, Ltd.

VOTIS-a revolutionary medical device to safely screen, stage and monitor the diabetic foot. We help you keep your feet!

Founded 2017 Israel

Israel 17 employees Seed Total: $4.77M Biotechnology, Health Care +1

VOTIS Subdermal Imaging Technologies is a biotechnology and healthcare startup based in Israel, founded in 2017. The company offers a revolutionary medical device, with the slogan "VOTIS-a revolutionary medical device to safely screen, stage and monitor the diabetic foot. We help you keep your feet!" VOTIS provides clinical decision support for the diagnosis and monitoring of diabetic foot syndrome and related conditions. The device is designed for safe and repeated use over time, as well as for acute use during surgical procedures. The process is non-invasive and ionizing-radiation-free, providing objective, repeatable, and measurable data useful to the doctor — regardless of treatment options being used. The startup recently received a $2.27M Seed Round investment on 21 April 2023 from Italian Angels for Growth. This investment serves as an indication of the confidence that the investing firm has in VOTIS and its potential within the medical technology space. This significant investment will likely be utilized for further research and development, market expansion, and potential regulatory approvals. Overall, VOTIS Subdermal Imaging Technologies is poised to make a substantial impact in the healthcare industry, particularly in the management of diabetic foot syndrome, and with the recent investment, it is well-positioned for future growth and success.

Funding Stage	Amount	Investors	Lead Investors	Date
Seed Round	$2.27M	1	Italian Angels for Growth	21 Apr 2023
Seed Round	$2.50M	-		01 Jun 2021
Non Equity Assistance	Undisclosed	1	MassChallenge	01 Nov 2017

Funding Stage

Amount

Investors

Lead Investors

Date

Seed Round

$2.27M

Italian Angels for Growth

21 Apr 2023

Seed Round

$2.50M

01 Jun 2021

Non Equity Assistance

Undisclosed

MassChallenge

01 Nov 2017

FAQ About VOTIS Subdermal Imaging Technologies, Ltd.

VOTIS-a revolutionary medical device to safely screen, stage and monitor the diabetic foot. We help you keep your feet!

VOTIS Subdermal Imaging Technologies, Ltd. was founded in 2017.

VOTIS Subdermal Imaging Technologies, Ltd. is headquartered in Israel.

VOTIS Subdermal Imaging Technologies, Ltd. operates in Biotechnology, Health Care and Medical Devices. Its work centres on medical device, diabetic foot, clinical decision support and non-invasive.

VOTIS Subdermal Imaging Technologies, Ltd. has approximately 17 employees.

VOTIS Subdermal Imaging Technologies, Ltd. has completed 3 funding rounds, raising a total of $4.77M. The latest funding stage is Seed.

Top alternatives and competitors to VOTIS Subdermal Imaging Technologies, Ltd. include Aireen, Centerline Biomedical, SuperSonic Imagine, ENDRA Life Sciences (Nasdaq: NDRA), SiBionics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

VOTIS Subdermal Imaging Technologies, Ltd. and Aireen are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

VOTIS Subdermal Imaging Technologies, Ltd.

General Information

Discover More

About VOTIS Subdermal Imaging Technologies, Ltd.

Funding Rounds & Investors (3)

VOTIS Subdermal Imaging Technologies, Ltd. Alternatives & Competitors

FAQ About VOTIS Subdermal Imaging Technologies, Ltd.